2020
The role of targeted therapy (TKI) in the treatment of advanced hepatocellular carcinoma (aHCC) in the era of immunotherapy: Real-world data using AI analytics from an academic medical center.
Wong R, Wu J, Leen A, Tey G, Asokumaran Y, Chan G, Siddappan C, Jeyasekharan A, Chee C, Yong W, Ngiam K, Sundar R. The role of targeted therapy (TKI) in the treatment of advanced hepatocellular carcinoma (aHCC) in the era of immunotherapy: Real-world data using AI analytics from an academic medical center. Journal Of Clinical Oncology 2020, 38: e16623-e16623. DOI: 10.1200/jco.2020.38.15_suppl.e16623.Peer-Reviewed Original ResearchAdvanced hepatocellular carcinomaEra of immunotherapySequence of therapySystemic therapyOverall survivalHCC patientsClinical outcomesManagement of advanced hepatocellular carcinomaTreated with first-line immunotherapyTreatment of advanced hepatocellular carcinomaFirst-line immunotherapyFirst-line TKIsSecond-line immunotherapySecond-line TKIsLoco-regional therapiesProgression-free survivalSecond-line therapySecond-line treatmentPillar of treatmentChild-Pugh scoreMinority of patientsSecond-lineFirst-lineMedian ageTargeted therapy
2017
Patterns of metastases in malignant pleural mesothelioma in the modern era: Redefining the spread of an old disease.
Collins D, Constantinidou A, Sundar R, Chenard-Poirier M, Yap T, Banerji U, De Bono J, Lopez J, Tunariu N. Patterns of metastases in malignant pleural mesothelioma in the modern era: Redefining the spread of an old disease. Journal Of Clinical Oncology 2017, 35: 8556-8556. DOI: 10.1200/jco.2017.35.15_suppl.8556.Peer-Reviewed Original ResearchMalignant pleural mesotheliomaDrug Development UnitMetastatic patternBone metastasesPleural mesotheliomaCohort of MPM patientsAdvanced malignant pleural mesotheliomaMalignant pleural mesothelioma patientsEpithelioid malignant pleural mesotheliomaSymptomatic brain metastasesMedian overall survivalSecond-line therapySite of metastasisPattern of metastasisLytic bone metastasesFDG-PET imagingUnusual metastasesVisceral metastasesBrain metastasesMPM patientsOverall survivalLung metastasesMedian ageBone scanOmental disease